Rejection

Refusal by a bank to grant credit, usually because of the applicants financial history, or refusal to accept a security presented to complete a trade, usually because of a lack of proper endorsements or violation of rules of a firm.

Rejection

1. A bank's refusal to grant a line of credit. This often applies to the refusal to grant a mortgage loan to an uncreditworthy person or a business loan to someone without a proper business plan.

2. An investor's refusal to accept a security presented to him/her/it. Reasons for this include suspicion of fraud or improperly filled-out forms.

3. Refusal to provide insurance coverage because the insurance company believes that the claim describes a service or situation that the policy does not cover.

rejection

The refusal to accept a security that has been delivered by a customer or broker. A questionable certificate or an improper endorsement are reasons for rejection.

Wall Street Words: An A to Z Guide to Investment Terms for Today's Investor by David L. Scott. Copyright © 2003 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved. All rights reserved.

Mentioned in

References in periodicals archive

Renal transplants: can acute rejection and acute tubular necrosis be differentiated with MR imaging?

RADIOLOGICAL IMAGING IN RENAL TRANSPLANTATION

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.

Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation

The logarithmic transformed mRNA levels of perforin and TIM-3 were higher in leukocytes from patients with acute rejection than in patients without rejection.

Non-invasive messenger RNA transcriptional evaluation in human kidney allograft dysfunction

In our patient, positive C4d immunostaining was an isolated finding on a planned allograft biopsy performed on POD 711; no clinical signs of rejection were observed, histopathology was not consistent with acute rejection, and the patient has not developed DSA.

Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody

The incidence of post-transfer predictors (medication nonadherence, acute rejection, change in kidney function) and the outcome of graft loss were analyzed by post-transfer time (see Table 2).

Post-transfer predictors of poor outcomes in pediatric renal transplant recipients

Acute rejection is characterized by a perivascular mononuclear cell infiltrate with or without endothelialitis.

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society

Of the 73 first episodes of CMV infection/disease, 56 (77%) occurred in high risk patients during preemptive therapy (1 D+/R-, 38 who received induction therapy, and 17 after treatment of acute rejection) and 17 (23%) in low risk patients (no induction, no D+/R-, no acute rejection) who had not received preemptive therapy.

Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation

The data were collected 1, 6, and 12 months after transplantation, and included presence of delayed graft function (DGF), acute rejection episodes, total hospital stay, and the laboratory parameters.

Effect of age on the outcome of renal transplantation: A single-center experience

Results: Multivariate analysis indicated that only partial liver graft (odds ratio [OR], 2.741; 95% confidence interval [CI], 1.236-6.077; P=0.013) was an independent risk factor for early-onset BC after LT, whereas acute rejection (OR, 6.556; 95% CI, 2.380-18.056; P < 0.001), multiple bile ducts (OR, 4.227; 95% CI, 1.212-14.740; P = 0.024), and pre-LT serum albumin level (OR, 2.234; 95% CI, 1.178-4.238; P = 0.014) were the independent risk factors for late-onset BC after LT.

Differences in risk factors for early-onset and late-onset biliary complications in liver transplant patients

As described in a study involving seven transplant centers recently published in the American Journal of Transplantation, peripheral blood gene expression profiling was used to classify kidney graft recipients into three key categories of graft status (acute rejection, acute dysfunction no rejection, an stable graft performance) with very high predictive accuracy.

Transplant Genomics obtains exclusive license to patent rights to develop genomics tests to improve organ transplant outcomes

Although development of immunosuppressive drugs and improvement of surgical techniques has been improved the outcome of kidney transplantation, acute rejection is a common phenomenon in transplantation [1].

Association of CD40 and IL-18 gene variants with kidney transplant rejection in Iranian patients